Cellectis.com

FDA Grants Cellectis IND Approval to Proceed with the Clinical

WebFebruary 6, 2017 – New York (N.Y.) – Cellectis (Alternext: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene …

Actived: 8 days ago

URL: https://www.cellectis.com/en/press/fda-grants-cellectis-ind-approval-to-proceed-with-the-clinical-development-of-ucart123-the-first-gene-edited-off-the-shelf-car-t-cell-product-candidate-developed-in-the-u.s/